Analysts at Credit Suisse raise their short-term USD/ZAR target range to 14.40-14.95 (from 13.60-14.40 previously) after the rand has been hit by adverse South-Africa-specific developments this week.
The main upside risk comes from the possibility of another round of dollar strength against EM currencies
“In the short run, the imprisonment of former president Zuma is likely to imply headline risk as well as real economic risk. Pro-Zuma protests may linger and become wide-spread enough to hurt retail sales and consumer confidence in a lasting manner. But over the longer-run, this development is likely to help president Ramaphosa consolidate his power within the ANC party. Therefore, it improves the chances for market-friendly reforms in the future.”
“We continue to think that covid developments in the country are unlikely to turn into a major hurdle for the rand or for South African assets in general.”
“We raise our short-term USD/ZAR target range to 14.40-14.95 (from 13.60- 14.40). The global landscape has changed into one in which investors are not rushing to sell the USD against EM currencies as they did in Q2. The top-end of our new range is set not far above the 200-day moving average – of around 14.85. Despite the underperformance of the rand so far this week there is still a substantial risk that this level will be broken.”
“We refrain from setting our new USD/ZAR forecast substantially higher from current levels after an already large underperformance of the rand and while the fiscal and the current account picture are generally supportive. The direction of the USD against the rest of the global currency complex matters more for USD/ZAR than local developments at this point. In other words, we expect the correlation between USDZAR and the BBDXY to remain high. A sustained rise in USD/ZAR to levels above our new range would likely require another sizable round of generalized USD appreciation.”
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.